首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncogenesis

缩写:ONCOGENESIS

ISSN:2157-9024

e-ISSN:2157-9024

IF/分区:6.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引958
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Zicheng Zhang,Hongyan Chen,Dongxue Yan et al. Zicheng Zhang et al.
Immune checkpoint blockade (ICB) therapies have brought unprecedented advances in cancer treatment, but responses are limited to a fraction of patients. Therefore, sustained and substantial efforts are required to advance clinical and trans...
Alvin Ho-Kwan Cheung,Kit-Yee Wong,Xiaoli Liu et al. Alvin Ho-Kwan Cheung et al.
MLK4, a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, has been implicated in cancer progression. However, its role in lung adenocarcinoma has not been characterized. Here, we showed that MLK4 was overexpressed...
Melanie Schoof,Gefion Dorothea Epplen,Carolin Walter et al. Melanie Schoof et al.
The tumor suppressor and chromatin modifier cAMP response element-binding protein binding protein (CREBBP) and v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN), a member of the MYC oncogene family, are critic...
Yuxing Wang,Ru Wang,Xiaohe Liu et al. Yuxing Wang et al.
Cancer relapse and metastasis are major obstacles for effective treatment. One important mechanism to eliminate cancer cells is to induce apoptosis. Activation of executioner caspases is the key step in apoptosis and was considered "a point...
Zhao Chen,Changyou Lin,Hong Pei et al. Zhao Chen et al.
Chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated potent clinical efficacy in the treatment of hematopoietic malignancies. However, the application of CAR-T in solid tumors has been limited due in part to the expression of i...
Leigh A Bumpous,Kylie C Moe,Jing Wang et al. Leigh A Bumpous et al.
Collectively, the MYC family of oncoprotein transcription factors is overexpressed in more than half of all malignancies. The ability of MYC proteins to access chromatin is fundamental to their role in promoting oncogenic gene expression pr...
Tao Ji,Qianyu Shi,Song Mei et al. Tao Ji et al.
Tumor thrombus of bone sarcomas represents a unique reservoir for various types of cancer and immune cells, however, the investigation of tumor thrombus at a single-cell level is very limited. And it is still an open question to identify th...
Yu Wang,Hongji Zhang,Alessandro La Ferlita et al. Yu Wang et al.
Chemotherapy remains the mainstay of treatment for patients with advanced liposarcoma (LPS), but response rates are only 25% and the overall survival at 5 years is dismal at 20-34%. Translation of other therapies have not been successful an...
Mariusz Shrestha,Dong-Yu Wang,Yaacov Ben-David et al. Mariusz Shrestha et al.
Immune-checkpoint (IC) modulators like the poliovirus receptor (PVR) and programmed death ligand 1 (PD-L1) attenuate innate and adaptive immune responses and are potential therapeutic targets for diverse malignancies, including triple-negat...
Manqiu Yang,Shufan Zhang,Rong Jiang et al. Manqiu Yang et al.
In cancer, extrachromosomal circular DNA (ecDNA), or megabase-pair amplified circular DNA, plays an essential role in intercellular heterogeneity and tumor cell revolution because of its non-Mendelian inheritance. We developed circlehunter ...